BioSpace News Archive

Iridex Corporation, a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, announced the company will present at the upcoming Inaugural Gilmartin Group Emerging Growth Company Showcase, taking place virtually.

Relay Therapeutics, Inc. (Nasdaq: RLAY), today announced that a late breaking abstract of interim clinical data from the ReFocus trial for RLY-4008 has been selected for an oral presentation at the upcoming European Society of Medical Oncology (ESMO) Congress, being held September 9-13, 2022.

TELA Bio, Inc. announced the closing of its previously announced underwritten public offering of 4,600,000 shares of its common stock at a price to the public of $8.00 per share, including 600,000 shares sold pursuant to the full exercise of the underwriter’s option to purchase additional shares, for gross proceeds of $36.8 million, before deducting underwriting discounts and commissions and other estimated offering expenses.

Vifor Fresenius Medical Care Renal Pharma is pleased to announce that England’s National Institute for Health and Care Excellence has recommended Tavneos® in combination with a rituximab or cyclophosphamide regimen for the treatment of adult patients with severe, active granulomatosis polyangiitis or microscopic polyangiitis, two main forms of AAV.

The Company’s revenue increased 113.7% YoY to RMB 1.53 billion in the first six months of 2022.

Royal Philips convenes an Extraordinary General Meeting of Shareholders and publishes the agenda with explanatory note.

Trial Library, Inc., an oncology clinical trials company, announced it has come out of stealth mode and received its first funding to address the need for equity in patient recruitment to oncology clinical trials.

BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the Saudi Food and Drug Authority (SFDA) has approved oral, once-daily ORLADEYO ® (berotralstat) to prevent attacks of hereditary angioedema (HAE) in adults and pediatric patients 12 years of age and older in Saudi Arabia.

Quoin Pharmaceuticals Ltd. today provides a business update and announces financial results for the second quarter of 2022 ended June 30, 2022.

Microbot Medical Inc. (Nasdaq: MBOT), announced that it will be presenting the Company’s Self-Cleaning Shunt (SCS) at the 16th Asian Australasian Congress of Neurological Surgeons (AACNS).